Avoiding an FDA Warning Letter with a Strong CAPA Program 2012
08 Nov 2012
Webinar
Key Topics
Differences in FDA`s QSR and ISO 13485 CAPA terminology
FDA`s most common findings related to CAPA Review samples of warning letters published by FDA for deficiencies in the CAPA system
How to define and document CAPA in the Quality System, including what needs to be included in the various stages of CAPA response, review and approval
How to address nonconformities in the CAPA system
Address Ownership, Timelines and Escalation of CAPAs
Who should Attend
Quality Managers
Regulatory Affairs professionals
Consultants
Quality Engineers
Quality System Auditors
R&D Management
Past Events
Avoiding an FDA Warning Letter with a Strong CAPA Program 2012 - 08 Nov 2012, Webinar (33497)
Avoiding an FDA Warning Letter with a Strong CAPA Program 2026
Important
Please, check "Avoiding an FDA Warning Letter with a Strong CAPA Program" official website for possible changes, before making any traveling arrangements
Event Categories
Government & Global Issues: Law & Regulations
Health & Medicine: Healthcare, Medical technology, Pharma
